Evidence map›Paper›PMID 38170151›Full record

ArticleEthiopian medical journal2022

Impact of COVID-19 on population health and economic wellbeing in Ethiopia: A national pilot survey.

Winini Belay, Tsegahun Manyazewal, Yimtubezinash Woldeamanuel, Eyasu Makonnen, Solomon Teferra, Adamu Addissie, Charlotte Hanlon, Tewodros Haile, Wondwossen Amogne, Damen Hailemariam and 15 more

Open access · greenAbstract read
In one paragraph

Article in Ethiopian medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 2 countries.

Winini BelayAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Tsegahun ManyazewalAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Yimtubezinash WoldeamanuelAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Eyasu MakonnenAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Solomon TeferraAddis Ababa University, WHO Collaborating Center for Mental Health Research and Capacity Building, Department of Psychiatry, College of Health sciences, Addis Ababa, Ethiopia.
Adamu AddissieAddis Ababa University, College of Health Sciences, School of Public Health, Addis Ababa, Ethiopia.
Charlotte HanlonAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Tewodros HaileAddis Ababa University, College of Health Sciences, Department of Internal Medicine, Addis Ababa, Ethiopia.
Wondwossen AmogneAddis Ababa University, College of Health Sciences, Department of Internal Medicine, Addis Ababa, Ethiopia.
Damen HailemariamAddis Ababa University, College of Health Sciences, School of Public Health, Addis Ababa, Ethiopia.
Azeb AsaminewAddis Ababa University, WHO Collaborating Center for Mental Health Research and Capacity Building, Department of Psychiatry, College of Health sciences, Addis Ababa, Ethiopia.
Kassahun HabtamuAddis Ababa University, College of Education and Behavioral Studies, School of Psychology, Addis Ababa University, Addis Ababa, Ethiopia.
Mesele ArayaAddis Ababa University, Department of Economics, Addis Ababa, Ethiopia.
Tigest AjemeAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Tigist EshetuAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Haileleuel BisratAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Kehabtimer ShiferawAddis Ababa University, College of Health Sciences, School of Public Health, Addis Ababa, Ethiopia.
Munir KassaMinistry of Health-Ethiopia, Addis Ababa, Ethiopia.
Aschalew AbaynehEthiopian Public Health Institute, Ministry of Health, Addis Ababa, Ethiopia.
Fentie AmbawBahir Dar University, College of Medicine and Health Sciences, School of Public Health, Bahir Dar, Ethiopia.
Yemane BerhaneAddis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Rahel GebremariamVoluntary Service Overseas (VSO), Ethiopia Country Office, Addis Ababa, Ethiopia.
Gail DaveyBrighton and Sussex Medical School, Global Health and Infection Department, Brighton, UK.
Girmay MedhinAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Abebaw FekaduAddis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Addis Ababa University · ETAfrica Centres for Disease Control and Prevention · ETAddis Continental Institute of Public Health · ETBahir Dar University · ETEthiopian Public Health Institute · ETGovernment of Ethiopia · ET

Funding

Ethiopia-Emory TB Research Training ProgramD43TW009127 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Kidist Bobosha · 2013 to 2026
$3.4M
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related InfectionsR01DA057940 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Shashi Kapadia · 2023 to 2026
$2.8M
FIC NIH HHS D43 TW009127NIDA NIH HHS R01 DA057940Wellcome Trust
6 · The paper itself

Abstract

Introduction: The COVD-19 pandemic has resulted in unprecedented global health and economic crisis, particularly in countries struggling with poverty. We conducted a national survey to understand the economic and health impacts of COVID-19 in Ethiopia. Methods: A pilot, population-based, cross-sectional survey was conducted among adults randomly selected from the Ethio Telecom list of mobile phone numbers. Participants underwent a comprehensive phone interview about the impact of COVID-19 on their economic well-being and the health-related risks associated with COVID-19. Results: Of 4,180 calls attempted, 1194 were answered, of which a successful interview was made with 614 participants. COVID-19 affected the family income of 343 [55.9%] participants, 56 [9.1%] lost their job, 105 [17.1%] perceived high stress in their household, and 7 [1.14%] reported death in their family in the past month. The odds of having a decreased income due to COVID-19 were 2.4 times higher among self-employed [adjusted odds ratio (AOR) 2.4, 95% CI (1.58-3.77)] and 2.8 times higher among unemployed [AOR 2.8, 95% CI (1.35-5.85)] participants. Two-hundred twenty-one [36%] participants had comorbidity in their household with hypertension, 72 [11.7%], diabetes,50 [8.1%], asthma, 48 [7.8%], and other chronic diseases, 51 [8.4%]. Forty-six [7.5%] participants had COVID-like symptoms in the previous month, where cough, headache, and fatigue were the most common. Conclusion: COVID-19 posed serious economic pressure on households. Self-employed and unemployed were the most affected. Continuous surveillance is needed to actively monitor the impact of COVID-19 in the community and safeguard the economic and health well-being of individuals and households.

Indexed as

ComorbidityCOVID-19economyEthiopia

Identifiers

PMID38170151
PMCPMC10760987
OpenAlexW4390594786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.